Rob Volansky

WASHINGTON — Chimeric antigen receptor nature-killing cell therapy achieved “efficacy, persistence and super safety” in a small cohort of patients

Clinical trial results in Sjögren's disease over the last decade have volleyed between encouraging successes and deflating failures, but with several new drugs advancing through the pipeline, hopes are high yet again.

The field of rheumatology has “left behind” patients with lupus from Africa — and across the global African diaspora — at nearly all academic and

Uptake of belimumab continues to outpace the use of anifrolumab among clinicians managing patients with systemic lupus erythematosus, according to a survey conducted by Spherix Global Insights.

Although artificial intelligence presents “exciting opportunities,” its use in patient care “must be regulated” to address biases in decision

When researchers at ACR Convergence 2024 presented positive data from the RESET RA study regarding vagus nerve stimulation in rheumatoid arthritis, it

Physician empathy has long been recommended — but not required — in the doctor-patient relationship.

The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal antibody product — but it may not be enough for immunocompromised populations.

On Wednesday, the Senate will hold the first of two scheduled hearings to consider the nomination of Robert F. Kennedy Jr. to lead the nation's health care apparatus as HHS secretary.

Inconsistent messaging and evolving recommendations surrounding COVID-19 vaccination protocols may have contributed to both hesitancy and fatigue regarding vaccines among patients, according to experts.